GgoogleJP first seen 4 d ago, last 2 d ago, peak #1
Sumitomo Pharma raises profit forecast on strong US sales
Original: 住友ファーマ 株価
Sumitomo Pharma reported a 17.3% rise in revenue, driven by growth of drugs such as Orgovyx in the United States. The company raised its full-year net profit forecast to 94 billion yen and said it will reinstate a year-end dividend of 15 yen. Investors are tracking the stock following the better-than-expected earnings update.
Why now: The company's earnings beat and upward revision of its profit forecast are drawing investor attention to the share price.
Rank over time, top of the chart is #1. 6 snapshots from 4 d ago to 2 d ago.
Evidence
- 【決算】住友ファーマ、17.3％増収 オルゴビクスなど米国の成長が牽引 | 日刊薬業 - 医薬品産業の総合情報サイト · 日刊薬業
- 寄前【成行注文】売り越しランキング キオクシア、レーザーテク、ＳＢＧ [08:35] · 株探
- 【注目決算】住友ファーマ、通期最終利益９４０億円へ上方修正、期末１５円で復配――米国主力薬が伸長 · https://kabu-ir.com/
API: https://socialmediatrends-api.osmike.com/v1/trends/4556643